Vishwa Shah
Chief Quality OfficerViatris
PharmaceuticalsView Profile →Senior Vice President, Clinical Development Unit Head, Internal Medicine · Regeneron Pharmaceuticals
Boaz Hirshberg is senior vice president and clinical development unit head for internal medicine at Regeneron Pharmaceuticals. He joined in 2021 after clinical leadership at BOL Pharma, AstraZeneca/MedImmune and Pfizer and co-founding Regio Biosciences.
Last reviewed: Oct 21, 2026
Senior Vice President, Clinical Development Unit Head, Internal Medicine Regeneron Pharmaceuticals
Last Reviewed: October 21, 2026
Boaz Hirshberg is senior vice president and clinical development unit head for internal medicine at Regeneron Pharmaceuticals. He joined in 2021 after clinical leadership at BOL Pharma, AstraZeneca/MedImmune and Pfizer and co-founding Regio Biosciences.
Hirshberg completed an internal medicine residency at Hadassah Medical Center in Jerusalem and an endocrine fellowship at the National Institutes of Health. He worked at Pfizer as an early clinical lead for diabetes programs before spending twelve years at AstraZeneca/MedImmune.
At MedImmune, he built and led the cardiovascular, renal and metabolism clinical therapeutic area. He later served as executive vice president and chief medical officer at BOL Pharma, a biotechnology company developing medical cannabis therapeutics, and co-founded Regio Biosciences.
He joined Regeneron in 2021. He oversees strategic program direction and clinical development across ophthalmology, cardiovascular disease, obesity and metabolism, immunology, inflammation, infectious disease and rare diseases. His internal medicine remit brings several therapeutic areas under a common clinical development leadership role.
Hirshberg earned his undergraduate and medical degrees from the Hebrew University. His subsequent training included an internal medicine residency at Hadassah Medical Center and an endocrine fellowship at the National Institutes of Health.